Robert Jones, MD
Clinical Cardiac Electrophysiology · Nashville, TNNPI 1144309121
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $38,863 of the $56,751 with a category attached, or 68.5%. Medtronic accounts for 87.6% of it on its own, with 23 other manufacturers making up the rest.
Across 219 payments — averaging $259.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$50K
- Medical Device Business Services, Inc.$5K
- Pfizer$958
- Biosense Webster, Inc.$645
- Abbott$280
- Merck$69
- plus $588 from 18 others
Across 3 payments — averaging $5218.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$16K
What the payments were for
- Consulting fees$38,86368%
- Speaking & faculty fees$7,20013%
- Travel & lodging$5,99011%
- Food & beverage$4,6908%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(3 entities) | 98 | $49,712 |
| Medical Device Business Services, Inc. | 7 | $4,500 |
| Pfizer | 60 | $958 |
| Biosense Webster, Inc. | 10 | $645 |
| Abbott | 7 | $280 |
| Merck | 5 | $69 |
| Novo Nordisk | 3 | $67 |
| AstraZeneca | 4 | $61 |
| E.r. Squibb & Sons, L.L.C. | 3 | $60 |
| Edwards Lifesciences | 2 | $47 |
| Altathera Pharmaceuticals LLC | 2 | $43 |
| CMP Pharma, Inc. | 2 | $40 |
| Philips North America LLC | 2 | $39 |
| Novartis | 2 | $32 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| Vital Connect, Inc | 1 | $26 |
| Atricure, Inc. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $19 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $14 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$56,751 in reported general payments places this provider in the 85th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.
See all clinical cardiac electrophysiology providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 499 | $531,105 |
| XareltoRivaroxaban | 88 | $101,837 |
| MultaqDronedarone Hcl | 33 | $44,459 |
| Dofetilide | 50 | $6,715 |
| Amiodarone Hcl | 139 | $4,662 |
| SotalolSotalol Hcl | 173 | $4,321 |
| Flecainide Acetate | 109 | $4,156 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 55 | $1,925 |
| Metoprolol Succinate | 97 | $1,445 |
| Propafenone Hcl | 14 | $1,168 |
| Metoprolol Tartrate | 122 | $764 |
| Carvedilol | 81 | $676 |
| Diltiazem 12hr ErDiltiazem Hcl | 11 | $574 |
| Warfarin Sodium | 31 | $406 |
| Losartan Potassium | 24 | $336 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $958 | $531,105499 claims |
| Sanofi-aventis U.S. LLCMultaq | $30 | $44,45933 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.
Other clinical cardiac electrophysiology in Nashville
- Stephen FahrigNashville$605K
- Gregory BashianNashville$361K
- William StevensonNashville$172K
- Sandeep DuggalNashville$151K
- Sean WhalenNashville$149K
- Harikrishna TandriNashville$97K
- Robert PickettNashville$95K
- Giovanni Davogustto CataldoNashville$42K
- Jonathan GandhiNashville$36K
- Ricardo LugoNashville$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.